The two most important numbers in Washington....the number of votes in takes to pass a bill in the House (218) and the number of votes it take to defeat a Republican filibuster (60) in the Senate. Big issues remain the same, financing (income tax v. high cost insuranc tax), public option or not, and state discretion. Affordability is also a concern, but it probably can't be addressed fully if the President's desire for total outlays to be $900 Billion or less over 10 years are held to. So, there will remain concerns about the ability of some uninsured to afford insurance that a mandate would force them to buy.
And WSJ says Pharma companies will make out better than insurance companies, at least according to what their stock prices since Labor Day say.